Pharnext : strengthens its Senior Leadership Team with the appointment of Scott Johnson as VP, Head of Quality

PARIS, France, January 4th, 2023, 08:30 am CET - Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases... | January 4, 2023

Related Keywords

United States ,Paris ,France General ,France ,Antoine Gravelle ,Poulenc Rorer ,Abhijit Pangu ,Hugo Brugi ,Xavier Paoli ,Scott Johnson ,Rob Quinn ,Raj Thota ,Company Senior Leadership Team ,Gan Lee Pharmaceuticals ,Warner Chilcott ,Laboratory Good Practices ,Pharnext Senior Leadership Team ,Pfizer Inc ,Quality Assurance At Lupin Pharmaceuticals ,Eastern University ,Company Quality ,Johnson ,United States Navy ,Head Of Regulatory Affairs ,Senior Leadership Team ,Oyster Point Pharma ,Oyster Point ,Quality Assurance ,Lupin Pharmaceuticals ,Organizational Management ,Good Manufacturing Practices ,Good Laboratory Practices ,Good Clinical Practices ,Chief Executive Officer ,Chief Medical Officer ,Chief Financial Officer ,Chief Operating Officer ,General Counsel ,Chief Manufacturing Officer ,Melissa Israel ,Clinical Operations ,Lee Pharmaceuticals ,Johnson Consumer ,Pfizer Consumer Healthcare ,Regulatory Affairs ,Pharnext Senior Leadership ,Pharnext Sa Stock Exchange ,News ,Information ,Press Release ,January ,M ,Pet ,Pharnext ,N ,Dvanced ,Stage ,Iopharmaceutical ,Company ,Developing ,Novel ,Herapeutics ,Or ,Eurodegenerative Alpha Fr001400bv89 ,